Anyplex™ II MTB/MDR/XDR Detection is a multiplex real-time PCR assay that detect Mycobacterium tuberculosis (MTB) with Ct value and identify 38 mutations associated with Drug-Resistance simultaneously. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.
Reagent for DNA Detection is provided, purchase of DNA extraction kit is unnecessary
Wide range of applicable specimens
Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB
WTC(Wild-type Control) and Internal Control (IC) for assay validity
Automated data interpretation and LIS interlocking with Seegene Viewer
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
Fast treatment decision by simultaneous screening and subtyping
Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
Utilization of the UDG system to prevent carry-over contamination
The results indicate the detection of MTB infection in the FAM channel, and the rifampicin-resistance mutation in the HEX channel and the Isoniazid-resistance mutation in the Cal Red 610 channel.
 The WTC is designed to be exhibited the same result pattern with drug-susceptible M. tuberculosis sample. The WTC reaction should be always performed in each testing run, and the drug-resistant result of unknown samples is analyzed on the basis of the result of WTC.
 Multi-Drug Resistance
 Extensively Drug Resistance